Nasal allergy myths complicate patient care
Myths and facts about nasal allergies
Help your patients know the facts and dispel the myths about nasal allergy treatment so they can get the relief they need.
- Work through vasoconstriction
- Cause rebounds
- Provide comprehensive relief
of nasal allergy symptoms
- Work to block 6 key inflammatory
mediators in the allergic cascade*
* Mechanism vs. most OTC allergy pills. FLONASE® acts on multiple inflammatory substances (histamine, prostaglandins, cytokines, tryptases, chemokines, and leukotrienes). The exact number and precise mechanism are unknown.
MYTH - It takes 2 weeks or more to get full nasal allergy relief with intranasal corticosteroid sprays.
FACT: In some patients, FLONASE® Allergy Relief starts to act in 2-4 hours. Most patients will have achieved some relief in nasal allergy symptoms in 12 hours and notable nasal allergy symptom improvement in 24-48 hours. Maximum benefit can be achieved in 3-4 days.1,3,4
FACT: Allergic rhinitis symptoms can have a powerful, negative impact on patients’ lives, at home, and at work, due to fatigue, trouble sleeping, and difficulty breathing.5-7
- TROUBLE SLEEPING5,6
- DIFFICULTY BREATHING7
The estimated number
of work days lost to
allergies per year is:
FACT: Intranasal corticosteroid sprays are recognized as first-line treatment for allergic rhinitis.9 Single-ingredient antihistamines only block histamine, while FLONASE® Allergy Relief works to block 6 key inflammatory mediators, including histamine, to reduce inflammation and relieve symptoms.*3,10,11
*Mechanism vs. most OTC allergy pills. FLONASE® acts on multiple inflammatory substances (histamine, prostaglandins, cytokines, tryptases, chemokines, and leukotrienes). The exact number and precise mechanism are unknown.
With <1% systemic
absorption, it does
FACT: FLONASE® Allergy Relief can be used once daily for up to 6 months in adults as part of a regular nasal allergy treatment regimen to manage troublesome allergy symptoms caused by1:
SAR: Seasonal Allergic Rhinitis1
PAR: Perennial Allergic Rhinitis1
FACT: For many patients, due to climate change and other environmental factors, allergic rhinitis symptoms can be a problem any time of year, particularly for those who are continually exposed to high levels of airborne allergens, such as pollen, mold spores, and house dust mites.14,15
- Data on file. GlaxoSmithKline. 2014.
- WebMD. Nasal spray: are you overdoing it? http://www.webmd.com/allergies/features/nasal-spray-are-you-overdoing-it?page=2. Accessed October 16, 2014.
- Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63(10):1292-1300.
- FLONASE Drug Facts Label.
- Brooks M. Allergic rhinitis a significant burden. Medscape website. http://www.medscape.com/viewarticle/739928. Published March 30, 2011. Accessed March 27, 2014.
- Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101(5):633-637.
- Sardana N, Craig TJ. Congestion and sleep impairment in allergic rhinitis. Asian Pac J Allergy Immunol. 2011;29(4):297-306.
- Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Managed Care. 1999;5(4, suppl):S235-S247.
- Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2008;63(suppl 86):8-160.
- Ratner PH, van Bavel JH, Martin BG, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract. 1998;47(2):118-125.
- Bachert C, Geveart P. Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators. Allergy. 1999;54(suppl 57):116-123.
- US Food and Drug Administration. FDA approves first generic version of FLONASE [news release]. Silver Spring, MD: US Food and Drug Administration; February 22, 2006. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108603.htm. Updated April 8, 2013. Accessed October 14, 2014.
- MedlinePlus. Prednisone. http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html. Accessed April 1, 2014.
- Beggs PJ. Impacts of climate change on aeroallergens: past and future. Clin Exp Allergy. 2004;34(10):1507-1513.
- Yawn BP. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same? Med Gen Med. 2006;8(1):23.